Crossmark

The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML)

Published Online: 2023-12-26

Published Print: 2024-03

Authors

Tayabali, Sarrah

Baker, Robert

Nacheva, Elisabeth

O’Nions, Jenny

Gupta, Rajeev

Wilson, Andrew J.

Xu, Ke https://orcid.org/0000-0002-2453-4475
License Information

Text and Data Mining valid from 2023-12-26

Version of Record valid from 2023-12-26
More Information

Article History

Received: 9 September 2023

Accepted: 17 December 2023

First Online: 26 December 2023

Declarations

:

: Not required for this audit.

: Not applicable.

: For this audit, consent for publication is not required.

: The authors declare no competing interests.

Document is current